Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
109.93
-2.07 (-1.85%)
At close: Oct 22, 2026, 4:00 PM EDT
109.80
-0.13 (-0.12%)
Pre-market: Oct 23, 2026, 4:01 AM EDT

Hinge Health Stock Forecast

Stock Price Forecast

According to 17 analysts polled by S&P Global, Hinge Health stock has a consensus rating of "Buy" and an average price target of $112.13. The average 1-year stock price forecast is 2.00% higher than the current stock price, while the lowest is $90 (-18.13%) and the highest is $140 (+27.35%).

Price Target: $112.13 (+2.00%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$90$112.13$110$140
Change-18.13%+2.00%+0.06%+27.35%

Analyst Ratings

The average analyst rating for Hinge Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy888899
Buy777777
Hold111111
Sell000000
Strong Sell000000
Total161616161717

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Buy
Maintains
$110
BuyMaintains$110+0.06%Oct 17, 2026
KeyBanc
KeyBanc
Buy
Maintains
$125 → $140
BuyMaintains$125 → $140+27.35%Oct 16, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$117
BuyMaintains$117+6.43%Oct 12, 2026
Barclays
Barclays
Buy
Reiterates
$100 → $110
BuyReiterates$100 → $110+0.06%Oct 12, 2026
Bank of America Securities
Bank of America Securities
Buy
Initiates
$110
BuyInitiates$110+0.06%Sep 29, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
860.61M
from 587.86M
Increased by 46.40%
Revenue Next Year
1.09B
from 860.61M
Increased by 26.46%
EPS This Year
2.40
from 2.62
Decreased by -8.43%
EPS Next Year
3.06
from 2.40
Increased by 27.44%
Fiscal YearFY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
292.73M390.40M587.86M860.61M
Revenue Growth
-33.37%50.58%46.40%
Gross Profit
194.18M300.59M469.30M739.55M
Gross Margin
66.33%77.00%79.83%85.93%
Operating Income
-130.51M-31.22M-546.37M241.45M
Net Income
-108.14M-11.93M-528.26M162.02M
EPS
--2.622.40
EPS Growth
----8.43%
Forward PE
--30.3245.82
Free Cash Flow
--179.60M298.99M
No. Analysts
---16
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High876.7M
Avg860.6M
Low856.2M

Revenue Growth

Revenue Growth202620272028
High
49.1%
Avg
46.4%
Low
45.7%

EPS Forecast

EPS202620272028
High3.39
Avg2.40
Low2.24

EPS Growth

EPS Growth202620272028
High
29.4%
Avg
-8.4%
Low
-14.5%